SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-15-011181
Filing Date
2015-02-17
Accepted
2015-02-17 14:49:41
Documents
1
Group Members
BRADLEY J. BOLZONBRIAN G. ATWOODCHARLES M. WARDENKIRK G. NIELSENREBECCA B. ROBERTSONROBIN L. PRAEGERROSS A. JAFFESAMUEL D. COLELLATHOMAS F. WOIWODEVERSANT VENTURE CAPITAL IV, L.P.VERSANT VENTURES IV, LLCWILLIAM J. LINK

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a15-4778_1sc13ga.htm SC 13G/A 394756
  Complete submission text file 0001104659-15-011181.txt   396701
Mailing Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104 650-233-2211
Versant Side Fund IV, L.P. (Filed by) CIK: 0001456591 (see all company filings)

IRS No.: 263614950 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 2525 28TH STREET SUITE 100 BOULDER CO 80301
Business Address 2525 28TH STREET SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Subject) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-86488 | Film No.: 15621273
SIC: 2834 Pharmaceutical Preparations